GeneDx Holdings Corp.
WGS- Exchange
- Nasdaq
- Industry
- Services-Health Services
- SEC CIK
- 0001818331
In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 10, 2026, 1:19 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $21.0M (4.9% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Mar 14, 2022 |
| Revenue | $427.5M | $305.4M | $202.6M | $234.7M | $212.2M |
| Cost of revenue | $129.4M | $111.1M | $112.6M | $261.4M | $228.8M |
| Gross profit | $298.2M | $194.4M | $90.0M | -$26.8M | -$16.6M |
| Research and development | $72.0M | $45.7M | $58.3M | $86.2M | $105.2M |
| Selling, general and administrative | $150.8M | $101.1M | $133.8M | $203.3M | $206.0M |
| Operating income | -$13.1M | -$23.2M | -$180.6M | -$667.7M | -$446.1M |
| Interest expense | – | – | – | $3.21M | $2.83M |
| Income tax | -$116.0K | -$343.0K | -$926.0K | -$49.1M | $0 |
| Net income | -$21.0M | -$52.3M | -$175.8M | -$549.0M | -$245.4M |
| EPS, basic | $-0.73 | $-1.94 | $-7.23 | $-1.63 | $-2.27 |
| EPS, diluted | $-0.73 | $-1.94 | $-7.23 | $-1.63 | $-2.27 |
| Weighted shares, basic | 28.6M | 26.9M | 24.3M | 337.8M | 108.1M |
| Weighted shares, diluted | 28.6M | 26.9M | 24.3M | 337.8M | 108.1M |
| Margins and growth | |||||
| Gross margin | 69.7% | 63.6% | 44.4% | -11.4% | -7.8% |
| Operating margin | -3.1% | -7.6% | -89.2% | -284.5% | -210.3% |
| Net margin | -4.9% | -17.1% | -86.8% | -233.9% | -115.6% |
| Revenue growth, year over year | +40.0% | +50.8% | −13.7% | +10.6% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Mar 14, 2022 |
| Cash and equivalents | $105.0M | $85.2M | $99.7M | $123.9M | $400.6M |
| Short-term investments | $66.3M | $56.0M | $30.5M | – | – |
| Accounts receivable | $74.4M | – | – | $42.6M | $26.5M |
| Inventory | $14.0M | $10.7M | $8.78M | $13.7M | $33.5M |
| Total current assets | $268.3M | $198.0M | $182.3M | $212.6M | $483.5M |
| Property, plant and equipment | $45.7M | $32.9M | $32.5M | $51.5M | $62.7M |
| Goodwill | $13.5M | – | – | – | – |
| Intangible assets | $168.5M | $158.6M | $172.6M | $186.7M | – |
| Total assets | $523.7M | $419.4M | $418.8M | $490.9M | $554.1M |
| Accounts payable | $2.46M | $7.95M | $10.2M | $46.0M | $44.7M |
| Short-term debt | $4.54M | $1.21M | $497.0K | $4.75M | $0 |
| Total current liabilities | $108.9M | $54.8M | $58.8M | $144.3M | $101.3M |
| Long-term debt | $48.2M | $51.9M | $52.7M | $6.25M | $11.0M |
| Total liabilities | $215.5M | $174.1M | $190.7M | $237.2M | $166.0M |
| Shareholders' equity | $308.2M | $245.2M | $228.0M | $253.7M | $388.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 12, 2026 | Jan 13, 2025 | Jan 8, 2024 | Jan 9, 2023 | Mar 14, 2022 |
| Operating cash flow | $33.3M | -$28.5M | -$180.1M | -$319.2M | -$190.4M |
| Capital expenditures | $19.0M | $5.49M | $5.25M | $7.16M | $9.40M |
| Free cash flow | $14.3M | -$34.0M | -$185.4M | -$326.3M | -$199.8M |
| Depreciation and amortization | $9.60M | $7.90M | $19.7M | $59.3M | $21.8M |
| Stock-based compensation | $32.2M | $9.14M | -$326.0K | $42.0M | $219.4M |
| Investing cash flow | -$61.5M | -$30.1M | -$43.7M | -$141.3M | -$20.8M |
| Financing cash flow | $48.0M | $44.2M | $186.2M | $197.3M | $493.7M |
| Net change in cash | $19.8M | -$14.5M | -$37.6M | -$263.2M | $282.5M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 7.5% | 3.0% | -0.2% | 17.9% | 103.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2026 | 30.0M | +3.7% | SEC |
| Jul 27, 2026 | 29.8M | +3.8% | SEC |
| May 1, 2026 | 29.7M | +4.0% | SEC |
| Feb 17, 2026 | 29.3M | +4.3% | SEC |
| Oct 24, 2025 | 28.9M | +5.2% | SEC |
| Jul 24, 2025 | 28.7M | +6.6% | SEC |
| Apr 23, 2025 | 28.5M | +9.1% | SEC |
| Feb 14, 2025 | 28.1M | +7.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Dec 31, 2020, from 13F share counts: 1-for-33 in Q2 2023.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.